Screener
USANA Health Sciences USNA Total Cost of Revenue
Discontinued — last reported Q1 '26
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Net sales | $250,218 | $249,539 |
| Cost of sales | 59,436 | 52,445 |
| Gross profit | 190,782 | 197,094 |
| Operating expenses: | ||
| Brand Partner incentives | 88,654 | 89,985 |
| Selling, general and administrative | 88,254 | 91,438 |
| Total operating expenses | 176,908 | 181,423 |
| Earnings from operations | 13,874 | 15,671 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's total cost of revenue?
- USANA Health Sciences (USNA) reported total cost of revenue of $59.44M in Q1 2026.
- How has USANA Health Sciences's total cost of revenue changed year-over-year?
- USANA Health Sciences's total cost of revenue increased by 13.3% year-over-year, from $52.45M to $59.44M.
- What is the long-term trend for USANA Health Sciences's total cost of revenue?
- Over 3 years (2022 to 2025), USANA Health Sciences's total cost of revenue has grown at a 1.2% compound annual growth rate (CAGR), from $193.89M to $200.85M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about USANA Health Sciences's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude